Geneva Capital Management’s Dorman Products DORM Stock Holding History
Bought
Maintained
Sold
Other funds holding DORM
KI
RA
Geneva Capital Management's DORM Position: Q2 2026 in Review
Geneva Capital Management reduced its Dorman Products (DORM) stake by 21% in Q2 2026, selling an estimated $13.9M and leaving 447,159 shares worth $61M. The position accounts for 1.4% of the portfolio, ranked #23.
Geneva Capital Management first reported a position in DORM in Q1 2020 and has held it in 26 quarters since. The position peaked at $70.9M in Q3 2025. 327 funds tracked by Wall St. Rank hold DORM as of Q2 2026.
- Geneva Capital Management held 447,159 shares of Dorman Products worth $61M as of Q2 2026.
- Geneva Capital Management sold 117,197 Dorman Products shares in Q2 2026, an estimated $13.9M.
- Dorman Products made up 1.4% of Geneva Capital Management's portfolio in Q2 2026, its #23 holding.
- Geneva Capital Management first reported a position in Dorman Products in Q1 2020 and has held it in 26 quarters since.
- Geneva Capital Management's Dorman Products position peaked at $70.9M in Q3 2025.
- 327 funds tracked by Wall St. Rank held Dorman Products as of Q2 2026.
Based on Geneva Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.